PT1062341E - Alergénios recombinantes mutantes - Google Patents

Alergénios recombinantes mutantes Download PDF

Info

Publication number
PT1062341E
PT1062341E PT99907345T PT99907345T PT1062341E PT 1062341 E PT1062341 E PT 1062341E PT 99907345 T PT99907345 T PT 99907345T PT 99907345 T PT99907345 T PT 99907345T PT 1062341 E PT1062341 E PT 1062341E
Authority
PT
Portugal
Prior art keywords
allergens
recombinant allergens
mutant recombinant
disclosed
recombinant
Prior art date
Application number
PT99907345T
Other languages
English (en)
Inventor
Hans-Henrik Ipsen
Michael Dho Spangfort
Joergen Nedergaard Larsen
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092687&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1062341(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of PT1062341E publication Critical patent/PT1062341E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT99907345T 1998-03-16 1999-03-16 Alergénios recombinantes mutantes PT1062341E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK36498 1998-03-16

Publications (1)

Publication Number Publication Date
PT1062341E true PT1062341E (pt) 2008-12-24

Family

ID=8092687

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99907345T PT1062341E (pt) 1998-03-16 1999-03-16 Alergénios recombinantes mutantes

Country Status (20)

Country Link
US (1) US20040091500A1 (pt)
EP (1) EP1062341B1 (pt)
JP (1) JP2002506648A (pt)
KR (1) KR20010041918A (pt)
CN (1) CN1332029C (pt)
AT (1) ATE408690T1 (pt)
AU (1) AU749749B2 (pt)
CA (1) CA2323687C (pt)
DE (1) DE69939584D1 (pt)
DK (1) DK1062341T3 (pt)
ES (1) ES2313776T3 (pt)
HK (1) HK1033591A1 (pt)
HU (1) HUP0101464A3 (pt)
IL (2) IL138339A0 (pt)
NO (1) NO328354B1 (pt)
NZ (1) NZ506665A (pt)
PL (1) PL194804B1 (pt)
PT (1) PT1062341E (pt)
WO (1) WO1999047680A1 (pt)
ZA (1) ZA200004819B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2258853B1 (en) * 2000-04-28 2016-06-08 Novozymes A/S Lipolytic enzyme variant
IT1318690B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti dell'allergene maggiore par j 2 di parietaria judaica.
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
ATE403152T1 (de) * 2000-10-17 2008-08-15 Besst Test Aps Test zum direkten nachweisen einer biologischen zelle in einer körperflüssigkeitsprobe
AU2002223505B2 (en) * 2000-11-16 2006-12-07 Alk-Abello A/S Mutant allergens
EP1219300B1 (en) * 2000-12-28 2006-12-06 BIOMAY Produktions- und Handels- Aktiengesellschaft Treatment of allergies
ATE448793T1 (de) * 2001-03-02 2009-12-15 Univ Rockefeller Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
EP1436627A2 (en) * 2001-10-05 2004-07-14 Novozymes A/S Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
WO2003096869A2 (en) * 2002-05-16 2003-11-27 Alk Abelló A/S Recombinant bet. v. 1. allergen mutants, methods and process thereof
CA2503886A1 (en) * 2002-11-01 2004-05-13 Alk-Abello A/S Recombinant protein variants
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
EP1599185A1 (en) 2003-02-28 2005-11-30 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
WO2005058474A1 (en) 2003-12-19 2005-06-30 Alk-Abelló A/S Cryogranulation and storage method for active pharmaceutical agents
CA2624503A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
ITMI20052517A1 (it) * 2005-12-29 2007-06-30 Lofarma Spa Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa
US20090169582A1 (en) * 2006-04-20 2009-07-02 National University Of Singapore Recombinant lactobacillus and use of the same
US20080199485A1 (en) * 2007-02-15 2008-08-21 Mannkind Corporation Method for enhancing T cell response
CA2682054A1 (en) 2007-03-28 2008-10-02 Alk-Abello A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
EP2028188A1 (en) 2007-08-21 2009-02-25 Biomay AG Hypoallergenic molecules
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
WO2010146171A1 (en) 2009-06-19 2010-12-23 Alk-Abelló A/S Novel manner of administering allergen in allergen specific immunotherapy
CN102584966A (zh) * 2011-11-14 2012-07-18 广州医学院第二附属医院 一种重组花生过敏原与突变体及其制备方法和应用
CN102603879A (zh) * 2012-03-30 2012-07-25 广州医学院第二附属医院 一种重组大豆过敏原与突变体及其制备方法和应用
CN102617715A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组真菌主要过敏原与突变体及其制备方法和应用
CN102690340A (zh) * 2012-03-30 2012-09-26 广州医学院第二附属医院 一种重组巴西坚果过敏原与突变体及其制备方法和应用
CN102617719A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组大米过敏原与突变体及其制备方法和应用
CN102675439A (zh) * 2012-03-31 2012-09-19 广州医学院第二附属医院 一种重组黑麦草花粉过敏原与突变体的制备方法和应用
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
CN111187606B (zh) * 2020-02-25 2022-06-14 江苏海洋大学 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
EP1051494B1 (en) * 1998-01-31 2009-04-29 The University of Arkansas Methods and reagents for decreasing allergic reactions
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.

Also Published As

Publication number Publication date
DE69939584D1 (de) 2008-10-30
HK1033591A1 (en) 2001-09-07
CA2323687A1 (en) 1999-09-23
NZ506665A (en) 2003-08-29
ATE408690T1 (de) 2008-10-15
IL138339A0 (en) 2001-10-31
CN1293710A (zh) 2001-05-02
HUP0101464A3 (en) 2004-10-28
EP1062341B1 (en) 2008-09-17
HUP0101464A2 (hu) 2001-08-28
NO328354B1 (no) 2010-02-01
KR20010041918A (ko) 2001-05-25
NO20004614D0 (no) 2000-09-15
AU749749B2 (en) 2002-07-04
CA2323687C (en) 2008-11-25
NO20004614L (no) 2000-10-26
CN1332029C (zh) 2007-08-15
ES2313776T3 (es) 2009-03-01
EP1062341A1 (en) 2000-12-27
JP2002506648A (ja) 2002-03-05
WO1999047680A1 (en) 1999-09-23
DK1062341T3 (da) 2008-11-03
US20040091500A1 (en) 2004-05-13
PL343029A1 (en) 2001-07-30
IL138339A (en) 2009-06-15
PL194804B1 (pl) 2007-07-31
AU2714799A (en) 1999-10-11
ZA200004819B (en) 2001-05-30

Similar Documents

Publication Publication Date Title
IL138339A0 (en) Mutant recombinant allergens
AU2350502A (en) Novel mutant allergens
WO2003020889A3 (en) Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
MXPA03011985A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
HUP0302965A2 (hu) Vakcina
MX9801159A (es) Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob.
BG102818A (en) D-manitol and method for its preparation
AU3227700A (en) Skin sanitizing compositions
IL145795A0 (en) Mutant human cd80 and compositions for and methods of making and using the same
MX9708426A (es) Polipeptido hk2 de variante estable.
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
ATE284708T1 (de) T-zellimpfung zur behandlung von multiple sclerosis
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
BG101787A (en) Aprotinine options having improved properties
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
IL153576A0 (en) Dna vaccines encoding hiv accessory proteins
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
WO1999015160A3 (en) Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies
WO2000027881A3 (de) Menschliche interleukin -10 mutantenproteine
WO2001048205A3 (en) Murine neu sequences and methods of use therefor
DE69225039D1 (de) Mikroorganismen und Verfahren zur Herstellung von 3-Alpha, 7-Alpha-Dihydroxy-12-Keto-Cholansäure